# Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?

> **NCT00257803** · NA · COMPLETED · sponsor: **University of British Columbia** · enrollment: 150 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Saline solution

## Key facts

- **NCT ID:** NCT00257803
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-10
- **Final completion:** 2012-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2014-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257803, "Does the Rapid Intravenous Administration of Oxytocin After Delivery of the Baby Decrease the Bleeding During Cesarean Section in Women at Risk of Bleeding During Cesarean Section?". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00257803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*